Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.4.1; removed the funding-lapse notice and Revision: v3.4.0.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a glossary toggle and updated metadata to display Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check23 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4 with no user-visible changes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedLocations were reorganized into a consolidated Locations section with multiple state entries. Per-state location headers were removed, the HHS Vulnerability Disclosure was deleted, and the page revision updated to v3.3.3.SummaryDifference0.9%

- Check74 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. No observable changes to study content or user-facing information in the screenshot.SummaryDifference0.0%

- Check81 days agoChange DetectedPubMed publications note updated to indicate that items are automatically filled from PubMed and may not all be about the study. Revision: v3.3.1 was added to the page.SummaryDifference0.1%

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.